Why is Nath Bio-Genes falling/rising?

As of 04-Sep, Nath Bio-Genes (India) Ltd is currently priced at 171.00, reflecting a slight increase of 0.05 or 0.03%. The stock has shown a trend reversal by gaining after two consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend overall. Despite a recent rise in delivery volume by 149.75% against the 5-day average, the stock has underperformed significantly over various periods, with a 1-year return of -21.31% and a 5-year return of -41.45%. The company's low Return on Equity (ROE) of 6.43% and a negative compound annual growth rate (CAGR) of -0.69% in operating profits over the last five years suggest weak long-term fundamental strength. Additionally, a decrease in institutional investor participation further complicates the stock's outlook. In the broader market context, while the Sensex has gained 0.80% over the past week, Nath Bio-Genes has declined by 1.72%, indicating underperformance relative to the benchmark. The stock's performance has been notably poor over the past year and three years, with returns significantly lagging behind the BSE500 index. This underperformance, coupled with the company's flat results and rising interest expenses, suggests that investors may be cautious about the stock's future prospects. Overall, the combination of weak fundamentals, declining institutional interest, and poor relative performance to the market contributes to the stock's current price movement.